{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:38Z","timestamp":1793407298594,"version":"4.5.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2016,10,2]]},"DOI":"10.3109\/03639045.2016.1160110","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T03:45:49Z","timestamp":1457408749000},"page":"1660-1668","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":46,"title":["Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation"],"prefix":"10.3109","volume":"42","author":[{"given":"Michele","family":"Pozzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rogueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3109\/10611860903434035"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00736-0"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.11.009"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1159\/000167321"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.06.019"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011.0924"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000199741.08517.99"},{"key":"CIT0008","first-page":"729","volume":"71","author":"Birkhoff M","year":"2009","journal-title":"Indian J Pharm Sci"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.61.09.0012"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.3109\/08958370903278077"},{"key":"CIT0011","first-page":"956","volume":"440","author":"Balducci AG","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019881706159"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.09.012"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/head.12583"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0333102409359314","volume":"30","author":"Djupesland PG","year":"2010","journal-title":"Cephalalgia"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-012-0108-9"},{"key":"CIT0017","unstructured":"Health USDO, Human Services F. Bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action. Rockville (MD): Drug Administration, Center for Drug Evaluation, Research; 2003. Available from: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm070111.pdf."},{"key":"CIT0018","first-page":"373","volume":"2011","author":"Coowanitwong I","year":"2011","journal-title":"RDD Europe"},{"key":"CIT0019","first-page":"32","volume":"44","author":"Ottaviano G","year":"2006","journal-title":"Rhinology"},{"key":"CIT0020","first-page":"94","volume":"12","author":"Papachristou A","year":"2008","journal-title":"Hippokratia"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.12.012"},{"key":"CIT0022","first-page":"163","volume":"72","author":"Carr RL.","year":"1965","journal-title":"Chem Eng"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(03)00142-X"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20090"},{"key":"CIT0025","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. 2003;1\u201337."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0804-7"},{"key":"CIT0027","volume-title":"Consistency of formulated preparations","author":"Great Britain SO.","year":"2015"},{"key":"CIT0028","unstructured":"Suzuki Y, Sekine K, Nagai T, et\u00a0al. Powdery pharmaceutical composition for nasal administration. 1986:US4613500."},{"key":"CIT0029","unstructured":"Dohi M, Nishibe Y, Makino Y, Fujii T. Powdery composition for nasal administration. 2010:US7731990B2."},{"key":"CIT0030","unstructured":"Kobayashi H, Makino Y, Suzuki Y. Pharmaceutical preparation for intra-airway administration. 2001:EP0606486."},{"key":"CIT0031","unstructured":"Makino Y, Kobayashi H, Suzuki Y. Pharmaceutical preparation for intra-airway administration. 1996:EP0606486A4."},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120025453"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019891105250"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1021\/bm070050x"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/B978-044451964-1\/50003-0"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1002\/9780470656792"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.3109\/03639048209022105"},{"key":"CIT0038","unstructured":"Dohi M, Nishibe Y, Makino Y, Fujii T. Powdery composition for nasal administration. 2005:US6881423B2."},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00264"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2014.05.005"},{"key":"CIT0041","volume-title":"Handbook of pharmaceutical excipients","author":"Rowe RC","year":"2012"},{"key":"CIT0042","first-page":"113","volume":"24","author":"Okuda M","year":"1986","journal-title":"Rhinology"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1155\/1998\/639710"}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/03639045.2016.1160110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:51:49Z","timestamp":1498276309000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/03639045.2016.1160110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,3,22]]},"published-print":{"date-parts":[[2016,10,2]]}},"alternative-id":["10.3109\/03639045.2016.1160110"],"URL":"https:\/\/doi.org\/10.3109\/03639045.2016.1160110","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}